Search Within

Ellen Marlese Basu

  1. "GSK Faculty"
Formats
  1. Meeting Abstract (35)
  2. Journal Article (29)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (64)
  2. GSK Faculty (64)
  3. Neuroblastoma Service (64)
  4. Pediatrics, Department of (64)
  5. Tow Center for Developmental Oncology (TCDO) (63)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (62)

More Groups

People
  1. Shakeel Modak (63)
  2. Brian Kushner (61)
  3. Nai-Kong Cheung (61)
  4. Stephen Roberts (56)
  5. Kim Kramer (34)
  6. Suzanne Wolden (20)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (8)
  4. 2022 (3)
  5. 2021 (5)
  6. 2020 (5)

More Years

Publications
  1. Pediatric Blood and Cancer (22)
  2. Journal of Clinical Oncology (10)
  3. International Journal of Radiation Oncology, Biology, Physics (5)
  4. Cancer (4)
  5. International Journal of Cancer (4)
  6. Neuro-Oncology (3)

More Publications

Publishers
  1. Wiley Periodicals, Inc (22)
  2. American Society of Clinical Oncology (10)
  3. Elsevier Inc. (5)
  4. John Wiley & Sons (4)
  5. Wiley Blackwell (4)
  6. American Association for Cancer Research (3)

More Publishers

Results (64)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical impact of ALK mutations in neuroblastoma
    Meeting Abstract

    O'Donohue, T.; Gulati, N.; Shukla, N.; Roberts, S.; Basu, E.; Kushner, B.; Cheung, N. K.; Modak, S.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • A curative approach to central nervous system metastases of neuroblastoma
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Mauguen, A.; Tomlinson, U.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Preliminary results of "HITS" pilot/phase II study
    Meeting Abstract

    Modak, S.; Kushner, B.; Flores, M.; Santa-Maria, V.; Garraus, M.; Basu, E.; Roberts, S.; Castaneda, A.; Gorostegui, M.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Preliminary results of HITS pilot/phase II study
    Meeting Abstract

    Mora, J.; Kushner, B. H.; Flores, M. A.; Santa-Maria, V.; Garraus, M.; Basu, E. M.; Roberts, S. S.; Castaneda, A.; Gorostegui, M.; Cheung, N. K. V.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab plus stepped-up dosing of GM-CSF for high-risk neuroblastoma (HR-NB): Efficacy against histologically-evident primary refractory metastases in bone marrow (BM)
    Meeting Abstract

    Kushner, B. H.; Modak, S.; Basu, E. M.; Roberts, S. S.; Cheung, N. K. V.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Reduced-dose radiation therapy to the primary site is effective for high-risk neuroblastoma: Results from a prospective trial
    Journal Article

    Casey, D. L.; Kushner, B. H.; Cheung, N. K. V.; Modak, S.; Basu, E. M.; Roberts, S. S.; LaQuaglia, M. P.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save
  • Humanized 3F8 anti-G(D2) monoclonal antibody dosing with granulocyte-macrophage colony-stimulating factor in patients with resistant neuroblastoma: A phase 1 clinical trial
    Journal Article

    Kushner, B. H.; Cheung, I. Y.; Modak, S.; Basu, E. M.; Roberts, S. S.; Cheung, N. K.
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Intraventricular 131I-labeled monoclonal antibody 8H9 (omburtomab) targeting the surface glycoprotein B7-H3 in patients with CNS malignancies
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Tomlinson, U.; Donzelli, M.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Pediatric Blood and Cancer (2018)

    Fulltext@MSK | Save
  • Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study
    Journal Article

    Modak, S.; Le Luduec, J. B.; Cheung, I. Y.; Goldman, D. A.; Ostrovnaya, I.; Doubrovina, E.; Basu, E.; Kushner, B. H.; Kramer, K.; Roberts, S. S.; more...
    OncoImmunology (2018)

    Fulltext@MSK | Save
  • Treatment and outcome of adult-onset neuroblastoma
    Journal Article

    Suzuki, M.; Kushner, B. H.; Kramer, K.; Basu, E. M.; Roberts, S. S.; Hammond, W. J.; LaQuaglia, M. P.; Wolden, S. L.; Cheung, N. K. V.; Modak, S.
    International Journal of Cancer (2018)

    Fulltext@MSK | Save